Tiedemann Advisors, LLC Atri Cure, Inc. Transaction History
Tiedemann Advisors, LLC
- $2.31 Billion
- Q3 2023
A detailed history of Tiedemann Advisors, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Tiedemann Advisors, LLC holds 7,263 shares of ATRC stock, worth $171,915. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,263
Previous 7,263
-0.0%
Holding current value
$171,915
Previous $358,000
11.17%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding ATRC
# of Institutions
239Shares Held
46.7MCall Options Held
95.7KPut Options Held
119K-
Vanguard Group Inc Valley Forge, PA4.75MShares$113 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.23MShares$100 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.65MShares$86.5 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.68MShares$63.5 Million0.48% of portfolio
-
Wellington Management Group LLP Boston, MA1.64MShares$38.8 Million0.01% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.1B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...